Key result
New-onset hypertension is linked to accelerated global cognitive decline.
Why the study?
Prevalent hypertension increases dementia risk and lowers cognitive function, but the magnitude of cognitive change following the onset of new hypertension remains uncertain.
Does new-onset hypertension accelerate cognitive decline in middle-aged and older adults?
Cohort (n=7,949)
Yes
Does new-onset hypertension accelerate cognitive decline in middle-aged and older adults?
Effect estimate: Beta -0.029 SD/year (95% CI -0.043 to -0.015)
p-value: p=<0.001
New-onset hypertension in middle-aged and older adults is associated with an accelerated long-term decline in global cognition, highlighting the importance of hypertension prevention for maintaining brain health.
Should not yet change practice; leaves open whether treating new-onset hypertension slows cognitive decline.
Individuals with prevalent hypertension are at an increased risk of developing dementia and tend to exhibit lower cognitive function. However, the magnitude of cognitive change following the onset of new hypertension remains uncertain. A cohort of 7949 adults aged 45 and older without hypertension at baseline was followed prospectively for 7 years. Cognitive assessments were conducted initially (wave 1) and at least once between wave 2 (2013) and wave 4 (2018). Cognitive function was evaluated using a global cognition score, derived as a composite measure from four distinct cognitive tests. Linear mixed-effects models were employed to estimate the changes in cognitive function at the onset of hypertension (intercept change) and the subsequent rate of cognitive decline (slope change) over the follow-up period. The models accounted for pre-hypertension cognitive trajectories and participant-specific factors, with interaction terms included for antihypertensive medication, age and educational level. Of the 7949 participants, 1993 (25.07%, mean age 58.8 ± 8.84 years, 48.0% male) developed new-onset hypertension. Both groups-those without hypertension and those with new-onset hypertension-experienced annual cognitive decline during the follow-up period. The onset of hypertension was not associated with an acute decrease in global cognition or performance on the four cognitive tests. However, after the onset of hypertension, participants exhibited a statistically significant accelerated decline in global cognition (- 0.029 SD/year; 95% CI - 0.043 to - 0.015; p < 0.001), attention and calculation (- 0.022 SD/year; 95% CI - 0.040 to - 0.004; p = 0.017), and orientation (- 0.022 SD/year; 95% CI - 0.038 to - 0.005; p = 0.010). No significant changes were observed in episodic memory (- 0.009 SD/year; 95% CI - 0.028 to 0.010; p = 0.346) or visuospatial abilities (- 0.013 SD/year; 95% CI - 0.032 to 0.006; p = 0.185). Interaction analyses indicated that the use of antihypertensive medication, age, and educational level moderated the extent of global cognitive decline post-hypertension onset. The onset of new hypertension was not associated with an immediate decline in cognitive function compared to individuals without hypertension. However, it was linked to more rapid declines in global cognition, orientation, and attention and calculation abilities over time. These findings underscore the potential importance of hypertension prevention for maintaining long-term brain health.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) conducted a cohort in Cognitive decline (n=7,949). New-onset hypertension vs. No hypertension was evaluated on Annual change in global cognition z-score post-hypertension onset (Beta -0.029 SD/year, 95% CI -0.043 to -0.015, p=<0.001). New-onset hypertension was associated with a statistically significant accelerated decline in global cognition (Beta -0.029 SD/year) over a 7-year follow-up period.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: